ArticleRadiology advances2025
Contrast-enhanced CT as a non-invasive alternative for lung shunt fraction estimation in hepatic transarterial radioembolization.
Article in Radiology advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- When is patient-specific lung shunt fraction necessary inRadiology advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: Estimation of the lung shunt fraction (LSF) is an integral part of liver radioembolization treatment planning to prevent excessive lung irradiation from arterio-venous shunting in the liver. Purpose: This study investigates the potential of contrast-enhanced computed tomography (CECT) as a non-invasive method for estimating LSF as an alternative for Materials and Methods: This single-center retrospective study included 30 consecutive patients who underwent Results: The cohort consisted of 23 male and 7 female patients with a median age of 66 years (interquartile range: 58-71), diagnosed with hepatocellular carcinoma ( Conclusion: Hypervascular-tumor-to-perfused volume ratio computed from CECT may offer a suitable alternative to
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.